AzTrials
AzTrials

WellbeingFelizMente2NCT04768959

Cultivating Well-being in Severe Psychiatric Conditions

A study testing FelizMente in people with Wellbeing, run by Universidad Complutense de Madrid at 1 site in Spain.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The multicomponet psychological intervention is called Feliz-Mente, with third generation therapy components that aims to improve wellbeing and self-enhancement. Without intervening directly on the symptoms, it is expected to increase positive experiences, the use of personal strengths and positive relationships, and… Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Wellbeing
What is being tested?
FelizMente
Could I receive a placebo?
No, everyone receives an active treatment
How many people
140 participants
Where
1 siteSpain
Study dates
25 Oct 2017to 25 Sep 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 1) were aged 18-65 years
  • 2) had a minimum of motivation and commitment to participate in group therapy

Who cannot join

  • 1) limited cognitive resources or serious formal thinking disorder and/or
  • 2) a concurrent diagnosis of substance dependence or a severe personality disorder that could interfere with benefiting from a psychotherapy group.

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Carmen Valiente

    Pozuelo de Alarcón, Madrid, 28223

Other trials in Spain

About this study

Official title: Cultivating Well-being Beyond Symptomatology in Severe Psychiatric Conditions: A Randomized Controlled Trial

The multicomponet psychological intervention is called Feliz-Mente, with third generation therapy components that aims to improve wellbeing and self-enhancement. Without intervening directly on the symptoms, it is expected to increase positive experiences, the use of personal strengths and positive relationships, and aims to build a more meaningful self-narrative in persons with severe psychiatric conditions. Feliz-Mente is a group intervention of 12 sessions in which participants are expected to perform exercises during and between sessions to improve treatment adherence and daily practice. The design for the present study is a randomized controlled trial, which compares the post-intervention measures of the experimental group (group receiving the intervention) with the post-intervention measures of the control group (treatment as usual + waiting list).

Conditions
Wellbeing
Being tested
FelizMente
Keywords
schizophrenia, severe psychiatric conditions, wellbeing, RCT, positive psychology, third-generation psychotherapy
Medical subject headings
Schizophrenia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • FelizMenteBehavioural

    Also called Positive psychotherapy

    The intervention aims to improve well-being, without denying the existence of symptoms or problems, focusing on generating positive emotions and actions congruent with the person's values through 11 weekly 90-minute group sessions. The multi-component intervention manual was composed of evidence-based exercises of Positive Psychoterapy Interventions, Acceptance and Commitment Therapy and Mindfulness and was theory driven according the broaden-and-build-theory (Fredrickson, 2001) and the self-serving model of paranoia (Murphy et al., 2018). It was also informed by previous pilot studies carried out on people with paranoid tendencies (see Valiente et al., 2020) and with Severe Psyquiatric Condition samples.

Study groups in NCT04768959
Study groupRoleWhat they receive
No Intervention: TAU + waiting listNo interventionThis control group is a waiting list group. Participants received treatment as usual (TAU). Once the RCT is finished, participants have the chance to participate in the intervention group.
Experimental: TAU + Feliz-Mente InterventionExperimentalFeliz-Mente (third generation psychotherapy):The intervention is delivered in a group format with a total of 12 sessions and a maximum of 10 patients per group. The protocol consists of specific exercises: 1: welcome and identification of emotions, 2: identification and amplification of positive emotions, 3: regulation of negative emotions, 4: gratitude, 5: forgiveness, 6: self-compassion, 7: personal strengths, 8: loving-kindness and positive interpersonal relationships, 9: values, 10: purpose of life, 11: resilience, 12: keeping the change and farewell party.
Receives: Behavioral: FelizMente

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Well-being

    Psychological Well-Being Scales (Ryff, 1995)

    Measured: Change from Well-being at 12 weeks and 6 months

  2. Well-being

    Satisfaction with life Scale ( Diener et al. 1985)

    Measured: Change from Well-being at 12 weeks and 6 months

Secondary outcomes (4)
  1. Self-esteem

    Rosenberg self-esteem scale (Rosenberg, 1965)

    Measured: Change from self-esteem at 12 weeks and 6 months

  2. Attachment

    Relationship Questionnaire (Bartholomew and Horowitz, 1991)

    Measured: Change from Attachment at 12 weeks and 6 months

  3. Psychological Symptoms

    Symptom Checklist 90-Revised (SCL-90-R; Derogatis, 2002)

    Measured: Change from Psychological Symptoms at 12 weeks and 6 months

  4. Experiential Avoidance

    The Acceptance and Action Questionnaire (AAQ; Hayes et al.,2004)

    Measured: Change from Experiential Avoidance at 12 weeks and 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Feb 2021
  2. Study start25 Oct 2017
  3. Primary completion25 Sep 2019
  4. Study completion25 Sep 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
140 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04768959
Sponsor's protocol ID
UniversityComplutenseMadrid
Acronym
FelizMente2
Status last verified
Feb 2021
First submitted
21 Feb 2021
Last updated
24 Feb 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Study Protocol Statistical Analysis Plan (SAP) Informed Consent Form (ICF) Clinical Study Report (CSR) Analytic Code

Questions about this trial

What is this clinical trial studying?

A study testing FelizMente in people with Wellbeing, run by Universidad Complutense de Madrid at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Feb 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Well-being (time frame: Change from Well-being at 12 weeks and 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Feb 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in